Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2615 results

Sort By:

Olaparib in the Treatment of BRCA1/2 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast Cancer

Study ID: NCT05522491
Start Date: 2026-09-01
End Date: 2031-09-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Take it

Sponsor

Hebei Medical University Fourth Hospital

Source: clinicaltrials.gov

Share:
Add to list

Immunothrombosis With Septic Shock Undergoing Renal Replacement Therapy With the OXIRIS Membrane

Study ID: NCT06440317
Start Date: 2026-04
End Date: 2027-05
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Hemofiltration membranes (the oXiris membrane® and the HF1400® membrane)

Sponsor

University Hospital, Bordeaux

Source: clinicaltrials.gov

Share:
Add to list

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

Study ID: NCT07285655
Start Date: 2026-04
End Date: 2031-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

344

Intervention / Treatment

L606

Placebo

Sponsor

Liquidia Technologies, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Promoting Maintenance of Change Following Brief Intervention for Alcohol Use

Study ID: NCT05712382
Start Date: 2026-09
End Date: 2027-05
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

160

Intervention / Treatment

Parent handbook

Coping with negative emotions

Problem-solving risky situations

Recovering from slips

Sponsor

University of Massachusetts, Amherst

Source: clinicaltrials.gov

Share:
Add to list

Ask Questions About Clinical Trials

Study ID: NCT07343297
Start Date: 2026-04-30
End Date: 2027-04-05
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

293

Intervention / Treatment

Ask Questions about Clinical Trials brochure

Sponsor

Barbara Ann Karmanos Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer

Study ID: NCT05874297
Start Date: 2026-03-01
End Date: 2026-11-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Best Practice

Internet-Based Intervention

Administration Questionnaire

Sponsor

Fred Hutchinson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of the Efficacy of Ponatinib in Ph+ ALL in the Real-world

Study ID: NCT07356960
Start Date: 2026-04-02
End Date: 2029-06-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

103

Intervention / Treatment
Sponsor

Italian Group of Adult Hematological Diseases

Source: clinicaltrials.gov

Share:
Add to list

Cervical Plexus Hydrodissection With D5W Versus NS for Treatment-Resistant PTSD

Study ID: NCT07382596
Start Date: 2026-03-01
End Date: 2029-04-01
Study Type

Interventional

Study Phase

Phase4

No. of Participants

50

Intervention / Treatment

Dextrose 5% in water bilateral injection

Normal saline bilateral injection

Sponsor

Dr. Dean Reeves Clinic

Source: clinicaltrials.gov

Share:
Add to list

A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)

Study ID: NCT07286266
Start Date: 2026-03-03
End Date: 2030-01-16
Study Type

Interventional

Study Phase

Phase3

No. of Participants

450

Intervention / Treatment

JSKKKHAAGH4

Paclitaxel

Pegylated liposomal doxorubicin (PLD)

Topotecan

Gemcitabine

Sponsor

GlaxoSmithKline

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate the Efficacy and Safty of 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)

Study ID: NCT07349329
Start Date: 2026-03-09
End Date: 2029-02-21
Study Type

Interventional

Study Phase

Phase3

No. of Participants

380

Intervention / Treatment

608

Placebo

Sponsor

sunshine GU Okey pharmaceutical (Shanghai) co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list